These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 34015444)

  • 1. 5-HT7 receptor activation rescues impaired synaptic plasticity in an autistic-like rat model induced by prenatal VPA exposure.
    Khodaverdi M; Rahdar M; Davoudi S; Hajisoltani R; Tavassoli Z; Ghasemi Z; Amini AE; Hosseinmardi N; Behzadi G; Janahmadi M
    Neurobiol Learn Mem; 2021 Sep; 183():107462. PubMed ID: 34015444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of electrophysiological and behavioral deficits mediated by 5-HT7 receptor upregulation following LP-211 treatment in an autistic-like rat model induced by prenatal valproic acid exposure.
    Rahdar M; Davoudi S; Dehghan S; Javan M; Hosseinmardi N; Behzadi G; Janahmadi M
    Neuropharmacology; 2024 Oct; 257():110057. PubMed ID: 38964596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid.
    Davoudi S; Rahdar M; Hosseinmardi N; Behzadi G; Janahmadi M
    Physiol Behav; 2023 Oct; 269():114286. PubMed ID: 37402416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperexcitability of hippocampal CA1 pyramidal neurons in male offspring of a rat model of autism spectrum disorder (ASD) induced by prenatal exposure to valproic acid: A possible involvement of Ih channel current.
    Hajisoltani R; Karimi SA; Rahdar M; Davoudi S; Borjkhani M; Hosseinmardi N; Behzadi G; Janahmadi M
    Brain Res; 2019 Apr; 1708():188-199. PubMed ID: 30537517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.
    Wu HF; Lu TY; Chu MC; Chen PS; Lee CW; Lin HC
    Neuropharmacology; 2020 Jan; 162():107736. PubMed ID: 31398381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.
    Fereshetyan K; Chavushyan V; Danielyan M; Yenkoyan K
    Sci Rep; 2021 Dec; 11(1):23471. PubMed ID: 34873263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in prenatal valproic acid-induced rat model of autism.
    Gholipour P; Ebrahimi Z; Mohammadkhani R; Ghahremani R; Salehi I; Sarihi A; Komaki A; Karimi SA
    Sci Rep; 2024 Jun; 14(1):13168. PubMed ID: 38849397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus.
    West PJ; Marcy VR; Marino MJ; Schaffhauser H
    Neuroscience; 2009 Dec; 164(2):692-701. PubMed ID: 19660530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous exercise training rescues hippocampal long-term potentiation in the VPA rat model of Autism: Uncovering sex-specific effects.
    Mohammadkhani R; Salehi I; Safari S; Ghahremani R; Komaki A; Karimi SA
    Neuroscience; 2024 Nov; 559():105-112. PubMed ID: 39214164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal neurons isolated from rats subjected to the valproic acid model mimic in vivo synaptic pattern: evidence of neuronal priming during early development in autism spectrum disorders.
    Traetta ME; Codagnone MG; Uccelli NA; Ramos AJ; Zárate S; Reinés A
    Mol Autism; 2021 Mar; 12(1):23. PubMed ID: 33676530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H3 receptor antagonist, ciproxifan, alleviates cognition and synaptic plasticity alterations in a valproic acid-induced animal model of autism.
    Taheri F; Esmaeilpour K; Sepehri G; Sheibani V; Ur Rehman N; Maneshian M
    Psychopharmacology (Berl); 2022 Aug; 239(8):2673-2693. PubMed ID: 35538250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
    Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
    Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
    Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-frequency repetitive transcranial magnetic stimulation alleviates abnormal behavior in valproic acid rat model of autism through rescuing synaptic plasticity and inhibiting neuroinflammation.
    Xu X; Li F; Liu C; Wang Y; Yang Z; Xie G; Zhang T
    Pharmacol Biochem Behav; 2024 Jul; 240():173788. PubMed ID: 38734150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
    Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
    Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal spatiotemporal expression pattern of progranulin and neurodevelopment impairment in VPA-induced ASD rat model.
    Lan J; Hu Y; Wang X; Zheng W; Liao A; Wang S; Li Y; Wang Y; Yang F; Chen D
    Neuropharmacology; 2021 Sep; 196():108689. PubMed ID: 34175324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the Hippocampal Networks in Valproic Acid-Induced Rat Autism Model.
    Bódi V; Májer T; Kelemen V; Világi I; Szűcs A; Varró P
    Front Neural Circuits; 2022; 16():772792. PubMed ID: 35185478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT
    Bobula B; Kusek M; Hess G
    Pharmacol Biochem Behav; 2024 Jul; 240():173779. PubMed ID: 38688436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting PPARα in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences.
    Scheggi S; Guzzi F; Braccagni G; De Montis MG; Parenti M; Gambarana C
    Mol Autism; 2020 Jul; 11(1):62. PubMed ID: 32718349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined the GABA-A and GABA-B receptor agonists attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
    Yang JQ; Yang CH; Yin BQ
    Behav Brain Res; 2021 Apr; 403():113094. PubMed ID: 33359845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.